PMVP PMV Pharmaceuticals, Inc.
PMVP stock: dilution, delisting risk — what the SEC filings say, updated every weekday morning.
What the filings say Pressure ▼
The company can sell stock into the market any day at prevailing prices — steady supply.
Radar 64 (elevated attention) · dilution pressure high · listing risk low · governance risk low · runway n/a · strongest signal: Offering (424B) (Aug 31, 2026)
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Get tomorrow's read on PMVP — free One email every weekday morning: what changed across PMVP and ~1,400 other microcaps, every claim linked to the filing.
64 Radar · attention score (0–100)
84 Dilution pressure · financing + balance sheet
32 Listing risk · exchange standards
0 Governance risk · reporting, auditor, going concern
Analyst note No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.
Pro on PMVP Alerts One email the morning PMVP files anything that matches your rules (types, minimum score, setups).
12-month history Every signal and setup for PMVP back a year, not just 30 days — see how the current setup built.
Full analyst notes What we noticed, evidence with links, what could prove us wrong, red-team caveats.
Full screener + CSV All 892 flagged companies, same-day, sortable and exportable.
Balance sheet (XBRL) n/a cash + short-term investments
n/a estimated runway (no OCF data)
n/a stockholders' equity
$53.4M public float (10-K cover)
n/a shares outstanding
Runway = liquidity ÷ monthly operating burn at the latest reported period. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Signal timeline Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
Date Signal Evidence Score Sep 2, 2026 ▼ Offering (424B) 424B5 prospectus supplement 2026-09-02; 2 prior 424B filings in 12m filing
48 Sep 2, 2026 ▼ ATM program “atm” language in 424B5 (424B5) filed 2026-09-02 filing
40 Sep 2, 2026 ▼ Delisting language “delisting notice” language in 8-K (EX-1.1) filed 2026-09-02 filing
32 Aug 31, 2026 ▼ Offering (424B) 424B5 prospectus supplement 2026-08-31; 0 prior 424B filings in 12m filing
51 Aug 31, 2026 ▼ ATM program “atm” language in 424B5 (424B5) filed 2026-08-31 filing
40 Aug 31, 2026 ▼ Offering (424B) 424B3 prospectus supplement 2026-08-31; 0 prior 424B filings in 12m filing
30
Quiet Alpha Automated SEC-filing intelligence for US microcaps. Updated every weekday morning from SEC EDGAR · last run 2026-09-22.
Newsletter ·
X ·
[email protected] Quiet Alpha is an automated financial research publication. It is not investment advice, not a recommendation to buy or sell any security, and not personalized to any reader. Data are derived from public SEC filings and may contain errors; verify against the source documents linked in each item. Quiet Alpha accepts no compensation from issuers. Microcap securities are illiquid and can lose most or all of their value.